CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionCigna Investments Inc /new
Latest Disclosed Ownership3,427 shares
Latest Disclosed Value $ 1,012
Cigna Investments Inc /new ownership in MX4A / CME Group Inc.

On May 11, 2026 - Cigna Investments Inc /new filed a 13F-HR form disclosing ownership of 3,427 shares of CME Group Inc. (DE:MX4A) valued at $875,427 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 3,427 shares of CME Group Inc.. The current value of the position is $746,401 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CME GROUP Common Stock 12572Q105 3,427 0 0.00 1 0.1558
2026-01-20 2025-12-31 13F CME GROUP Common Stock 12572Q105 3,427 -77 -2.20 1 0.1350
2025-10-22 2025-09-30 13F CME GROUP Common Stock 12572Q105 3,504 -41 -1.16 1 0.1334
2025-07-15 2025-06-30 13F CME GROUP Common Stock 12572Q105 3,545 -93 -2.56 1 0.1662
2025-05-15 2025-03-31 13F CME GROUP Common Stock 12572Q105 3,638 -50 -1.36 1 0.1793
2025-01-29 2024-12-31 13F CME GROUP Common Stock 12572Q105 3,688 0 0.00 1 0.1497
2024-10-28 2024-09-30 13F CME GROUP Common Stock 12572Q105 3,688 -61 -1.63 1 0.1433
2024-07-17 2024-06-30 13F CME GROUP Common Stock 12572Q105 3,749 -45 -1.19 1 0.1364
2024-04-23 2024-03-31 13F CME GROUP Common Stock 12572Q105 3,794 -29 -0.76 1 0.1538
2024-01-22 2023-12-31 13F CME GROUP Common Stock 12572Q105 3,823 -27 -0.70 1 0.1655
2023-10-23 2023-09-30 13F CME GROUP Common Stock 12572Q105 3,850 -522 -11.94 1 0.1757
2023-08-01 2023-06-30 13F CME GROUP Common Stock 12572Q105 4,372 -20 -0.46 1 0.1504
2023-05-11 2023-03-31 13F CME GROUP Common Stock 12572Q105 4,392 -87 -1.94 1 0.1671
2023-02-13 2022-12-31 13F CME GROUP Common Stock 12572Q105 4,479 1 0.02 1 0.1562
2022-11-14 2022-09-30 13F CME GROUP Common Stock 12572Q105 4,478 -143 -3.09 1 0.1756
2022-08-15 2022-06-30 13F CME GROUP Common Stock 12572Q105 4,621 -1,723 -27.16 1 -100.00 0.1879
2022-05-13 2022-03-31 13F CME GROUP Common Stock 12572Q105 6,344 -1,820 -22.29 2 0.00 0.1852
2022-02-14 2021-12-31 13F CME GROUP Common Stock 12572Q105 8,164 -2,911 -26.28 2 -50.00 0.1457
2021-11-12 2021-09-30 13F CME GROUP Common Stock 12572Q105 11,075 -233 -2.06 2 0.00 0.1597
2021-08-10 2021-06-30 13F CME GROUP Common Stock 12572Q105 11,308 -1,650 -12.73 2 0.00 0.1717
2021-05-10 2021-03-31 13F CME GROUP Common Stock 12572Q105 12,958 373 2.96 3 0.00 0.1818
2021-02-11 2020-12-31 13F CME GROUP Common Stock 12572Q105 12,585 1,000 8.63 2 100.00 0.1770
2020-11-12 2020-09-30 13F CME GROUP Common Stock 12572Q105 11,585 -4,215 -26.68 2 -99.96 0.1867
2020-08-17 2020-06-30 13F CME GROUP Common Stock 12572Q105 15,800 5,756 57.31 2,567 47.78 0.2425
2020-05-11 2020-03-31 13F CME GROUP Common Stock 12572Q105 10,044 550 5.79 1,737 -15.76 0.2237
2020-02-04 2019-12-31 13F CME GROUP Common Stock 12572Q105 9,494 -1,018 -9.68 2,062 -4.67 0.2182
2019-11-07 2019-09-30 13F CME GROUP Common Stock 12572Q105 10,512 536 5.37 2,163 11.49 0.2233
2019-08-12 2019-06-30 13F CME GROUP Common Stock 12572Q105 9,976 -310 -3.01 1,940 14.59 0.2106
2019-05-10 2019-03-31 13F CME GROUP Common Stock 12572Q105 10,286 -171 -1.64 1,693 -13.89 0.1873
2019-02-06 2018-12-31 13F CME GROUP Common Stock 12572Q105 10,457 582 5.89 1,966 8.68 0.1666
2018-11-13 2018-09-30 13F CME GROUP Common Stock 12572Q105 9,875 -939 -8.68 1,809 2.03 0.1451
2018-08-14 2018-06-30 13F CME GROUP Common Stock 12572Q105 10,814 -1,583 -12.77 1,773 -11.57 0.1281
2018-05-09 2018-03-31 13F CME GROUP Common Stock 12572Q105 12,397 -178 -1.42 2,005 9.15 0.1344
2018-01-26 2017-12-31 13F CME GROUP Common Stock 12572Q105 12,575 -483 -3.70 1,837 3.67 0.1199
2017-10-11 2017-09-30 13F CME GROUP COM CL A 12572Q105 13,058 -150 -1.14 1,772 7.13 0.1181
2017-08-01 2017-06-30 13F CME GROUP INC 12572Q105 COM 12572Q105 13,208 -858 -6.10 1,654 -1.02 0.1137
2017-05-15 2017-03-31 13F CME GROUP INC 12572Q105 COM 12572Q105 14,066 1,538 12.28 1,671 15.64 0.1150
2017-02-15 2016-12-31 13F CME GROUP INC 12572Q105 COM 12572Q105 12,528 12,528 1,445 0.1574
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.